OmniSYS Appoints New CTO
September 21, 2017DALLAS, TX – September 21, 2017 – OmniSYS, a leading provider of billing, compliance, and patient- engagement solutions for pharmacies, pharmaceutical manufactures and medical equipment suppliers, announced the company has hired a new executive to help guide the company’s technology transformation. Effective immediately, Chris Harding assumes the position of chief technology officer. In this role he will head the OmniSYS information technology organization, serving as the champion of data security, innovation and the technology roadmap.
“The business requirements of the pharmacy industry continue to evolve. As a healthcare technology company it’s imperative that we stay at the forefront of innovation and continue to make the necessary investments to help our customers engage consumers, compete on value and differentiate their brands,” said John King, chief executive officer of OmniSYS. “We are thrilled to have Chris join our team and steer our efforts in this area.”
Harding has a proven track record in guiding technology organizations in both payer and provider systems. Prior to joining OmniSYS, he was the principal at C Harding Software Consultants where he helped Fortune 100 Companies align strategy with innovation efforts in order to build and deliver cutting edge software solutions. In the decades preceding, Harding held senior healthcare leadership information technology roles at MedAssets, OptumInsight and Delphi Technology where he oversaw responsibility for large software engineering organizations.
“I am extremely excited to join OmniSYS and work with John, the leadership team and the board to deliver to our customers a best in class experience in using the OmniSYS products,” said Chris Harding. “The breadth, depth and potential of the OmniSYS offerings far exceed anything else offered in the pharmacy space. I look forward to leading the technology efforts that will emphasize on innovation.”
Recent Press Releases
-
Oct 8, 2026
Diagnostic Lab Claim Denials Jumped 40% in 2025, New XiFin Research Report Finds
-
Sep 30, 2026
XiFin Launches Fourth Annual Pharmacy Transformation Outlook Survey as Legislative Action Moves to Reshape Pharmacist-Provided Care
-
Sep 24, 2026
Frost Radar™ Recognizes XiFin as the Only AI-enabled Ancillary Healthcare RCM Specialist Among Leading North American Providers
-
Aug 25, 2026
XiFin Research Quantifies Millions in Recoverable Revenue Across Ancillary Healthcare Revenue Cycles
-
Aug 18, 2026
XiFin Appoints Chris Martin as Chief Product Officer, Continues Building Award-Winning Leadership Team